Our researchers will produce clinical grade human embryonic stem (hES) cells for the treatment of a wide range of diseases and for use in tissue engineering and regenerative medicine. Our projects focus on:
- The establishment of GMP embryology and derivation of GMP hES cell lines.
- Targeted differentiation to insulin-secreting cells
- Targeted differentiation to chondrocytes
- Pluripotency and self renewal
- The stem cell niche
You can find out further details by exploring